---
stable_id: R-HSA-5634221
display_name: TRAF1 binds TRAF2 within TNFR1 signaling complex
species: Homo sapiens
summary: 'TNF-induced NFkappaB activates a group of gene products including TNF receptor
  associated factor (TRAF) family members and inhibitor of apoptosis proteins (BIRC
  or cIAP1/2). TRAFs and cIAP1/2 proteins may function cooperatively at the earliest
  checkpoint to suppress TNF-α-induced apoptosis (Rothe M et al. 1994,1995; Wang CU
  et al. 1998).<p>The TRAFs (TRAF1 to TRAF6) are a group of structurally similar adaptor
  proteins, in most cases with E3 ligase activity, that are involved in downstream
  signaling of various cell surface receptors such as TNFR1, TNFR2, CD40, TLRs and
  TCR (Jang HD et al. 2001; Fotin-Mleczek M et al. 2004; Su X et al. 2006). The hallmark
  feature of all TRAFs is a C-terminal TRAF-domain of approximately 230 amino acids,
  which is responsible for homo- and heterooligomerization of TRAF molecules (Rothe
  M et al. 1994). The differences in amino acid sequences in TRAF-domains define the
  range of TRAF interaction partners. Another important structural element of TRAFs,
  with an exception of TRAF1, is the N-terminal RING finger domain that modulates
  induction of NFkappaB and MAPK activities. As TRAF1 has no RING finger domain, the
  effects of TRAF1 on NFkB activation are rather unclear. It is believed that TRAF1
  regulates TNF receptor activity through its ability to interact with TRAF2 (Rothe
  M et al.1995; Zheng C et al. 2010; Fotin-Mleczek M et al. 2004). Structural and
  biochemical studies showed that TRAF1:TRAF2 heterotrimer (1:2) binds BIRC (cIAP2)
  more strongly than TRAF2 homotrimers, suggesting that TRAF1 may modulate the interaction
  between TRAF2 and BIRC (cIAP1/2) and thus suppress TNF-alpha induced apoptosis (Zheng
  C et al. 2010). Noteworthy, TRAF1:TRAF2 heterotrimers and TRAF2 homotrimers also
  differ in their capability with certain receptors but there seems to be no difference
  with respect to TNFR1 recruitment (Fotin-Mleczek M et al. 2004). On the contrary,
  TNF-induced caspase-mediated cleavage of TRAF1 generates a C-terminal fragment with
  NFkB-inhibitory, pro-apoptotic activity (Leo e et al. 2001; Jang HD et al. 2001;
  Henkler F et al. 2003). Thus, the current data suggest that depending on its cleavage
  status TRAF1 may exert either cytoprotective or cytotoxic effect in death domain-containing
  receptor signaling pathways.<p>The heteromeric complex TRAF1:TRAF2 has been also
  implicated in the cross-talk of TNFR1 and TNFR2 (Wicovsky A et al. 2009). '
---

# TRAF1 binds TRAF2 within TNFR1 signaling complex
**Reactome ID:** [R-HSA-5634221](https://reactome.org/content/detail/R-HSA-5634221)
**Species:** Homo sapiens

## Summary

TNF-induced NFkappaB activates a group of gene products including TNF receptor associated factor (TRAF) family members and inhibitor of apoptosis proteins (BIRC or cIAP1/2). TRAFs and cIAP1/2 proteins may function cooperatively at the earliest checkpoint to suppress TNF-α-induced apoptosis (Rothe M et al. 1994,1995; Wang CU et al. 1998).<p>The TRAFs (TRAF1 to TRAF6) are a group of structurally similar adaptor proteins, in most cases with E3 ligase activity, that are involved in downstream signaling of various cell surface receptors such as TNFR1, TNFR2, CD40, TLRs and TCR (Jang HD et al. 2001; Fotin-Mleczek M et al. 2004; Su X et al. 2006). The hallmark feature of all TRAFs is a C-terminal TRAF-domain of approximately 230 amino acids, which is responsible for homo- and heterooligomerization of TRAF molecules (Rothe M et al. 1994). The differences in amino acid sequences in TRAF-domains define the range of TRAF interaction partners. Another important structural element of TRAFs, with an exception of TRAF1, is the N-terminal RING finger domain that modulates induction of NFkappaB and MAPK activities. As TRAF1 has no RING finger domain, the effects of TRAF1 on NFkB activation are rather unclear. It is believed that TRAF1 regulates TNF receptor activity through its ability to interact with TRAF2 (Rothe M et al.1995; Zheng C et al. 2010; Fotin-Mleczek M et al. 2004). Structural and biochemical studies showed that TRAF1:TRAF2 heterotrimer (1:2) binds BIRC (cIAP2) more strongly than TRAF2 homotrimers, suggesting that TRAF1 may modulate the interaction between TRAF2 and BIRC (cIAP1/2) and thus suppress TNF-alpha induced apoptosis (Zheng C et al. 2010). Noteworthy, TRAF1:TRAF2 heterotrimers and TRAF2 homotrimers also differ in their capability with certain receptors but there seems to be no difference with respect to TNFR1 recruitment (Fotin-Mleczek M et al. 2004). On the contrary, TNF-induced caspase-mediated cleavage of TRAF1 generates a C-terminal fragment with NFkB-inhibitory, pro-apoptotic activity (Leo e et al. 2001; Jang HD et al. 2001; Henkler F et al. 2003). Thus, the current data suggest that depending on its cleavage status TRAF1 may exert either cytoprotective or cytotoxic effect in death domain-containing receptor signaling pathways.<p>The heteromeric complex TRAF1:TRAF2 has been also implicated in the cross-talk of TNFR1 and TNFR2 (Wicovsky A et al. 2009). 
